MOLECULAR VISION LIMITED
Get an alert when MOLECULAR VISION LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2027-03-31 (in 10mo)
Last filed for 2025-06-30
Confirmation statement due
2026-10-08 (in 5mo)
Last made up 2025-09-24
Watchouts
None on the register
Cash
£72K
+1% highest in 3 filed years
Net assets
-£2M
-4.4% lowest in 3 filed years
Employees
1
0% vs 2024
Profit before tax
-£87K
+34.9% highest in 3 filed years
Net assets
7-year trend · vs Industrials median
Accounts
7-year trend · latest reflected 2025-06-30
| Metric | Trend | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | — | — | |
| Operating profit | — | — | — | — | — | -£46,484 | £2,223 | |
| Profit before tax | — | — | — | — | -£100,158 | -£133,875 | -£87,108 | |
| Net profit | — | — | — | — | -£100,158 | -£133,875 | -£87,108 | |
| Cash | — | — | — | — | £68,170 | £70,828 | £71,537 | |
| Total assets less current liabilities | — | — | — | — | -£121,298 | — | — | |
| Net assets | — | — | — | — | -£1,841,264 | -£1,975,139 | -£2,062,247 | |
| Equity | -£1,304,036 | -£1,563,798 | -£1,666,017 | -£1,741,106 | -£1,841,264 | -£1,975,139 | -£2,062,247 | |
| Average employees | — | — | — | — | 2 | 1 | 1 | |
| Wages | — | — | — | — | — | — | — | |
| Directors' remuneration | — | — | — | — | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2024 → FY2025 · period ending 2025-06-30 vs 2024-06-30
-
Turnover
—
Not reported
-
Cash
+1%
£70,828 £71,537
highest in 3 filed years
-
Net assets
-4.4%
-£1,975,139 -£2,062,247
lowest in 3 filed years
-
Employees
0%
1 1
-
Operating profit
+104.8%
-£46,484 £2,223
-
Profit before tax
+34.9%
-£133,875 -£87,108
highest in 3 filed years
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|---|---|---|---|---|
| Current ratio | — | — | — | — | — | 0.03x | 0.03x | |
| Interest cover | — | — | — | — | — | -0.52x | 0.02x |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- MOLECULAR VISION LIMITED 2001-09-27 → present
- MELECULAR VISION LIMITED 2001-09-24 → 2001-09-27
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- RSM UK Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Company is part of Abingdon Health plc (the "Group") and relies on financial support of the Group to continue as a going concern... The Directors have a reasonable expectation that the Group and Parent Company, and hence the Company, have adequate resources to continue in operational existence for the foreseeable future.”
Significant events
- “The principal activity of the company changed during the year from that of research and experimental development on natural sciences and engineering to that of a holding Company for intellectual property for the Abingdon Health Plc group.”
- “The Group met its day to day working capital requirements through cash resources held with Barclays Bank plc, as well as an equity fundraise in August 2024 which provided £5.6 million (£5.2 million net of expenses).”
- “Subsequent to 30 June 2025, the Company completed an additional equity fundraise in October 2025 which raised £3.4 million (£3.2 million net of expenses) from institutional and retail investors for working capital purposes and further expansion of Abingdon Health USA Inc.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 31 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HAYES, Thomas Edward | Secretary | 2025-04-30 | — | — |
| HAND, Christopher William, Dr | Director | 2025-04-30 | May 1961 | British |
| YATES, Chris Henry Francis | Director | 2022-06-28 | Feb 1974 | British |
Show 31 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BATEMAN, Malcolm Richard | Secretary | 2009-10-19 | 2012-01-05 |
| CAIRNS, Judith | Secretary | 2006-10-18 | 2009-09-24 |
| MARLOW, Richard James | Secretary | 2014-05-19 | 2019-09-11 |
| PAGE, Scott Andrew | Secretary | 2019-09-11 | 2022-06-28 |
| PATERSON, Alexander Nicholas | Secretary | 2001-09-24 | 2006-10-18 |
| ROSS, Melanie | Secretary | 2022-06-28 | 2023-10-18 |
| YATES, Chris | Secretary | 2023-10-18 | 2025-04-30 |
| SWIFT INCORPORATIONS LIMITED | Corporate Nominee Secretary | 2001-09-24 | 2001-09-24 |
| AINSWORTH, Peter James, Dr | Director | 2003-05-27 | 2005-05-05 |
| ATUN, Rifat Ali, Prof. | Director | 2005-05-05 | 2007-07-30 |
| BHAMAN, Maina | Director | 2008-04-21 | 2012-03-22 |
| BRADLEY, Donal Donat Conor, Professor | Director | 2001-11-27 | 2012-03-22 |
| BYRNE, Kevin | Director | 2001-09-24 | 2001-11-27 |
| CAMPBELL, Ian William, Dr | Director | 2007-08-22 | 2011-01-31 |
| DE MELLO, Andrew James, Dr | Director | 2001-11-27 | 2007-07-30 |
| DE MELLO, John, Dr | Director | 2009-08-20 | 2012-03-22 |
| DE MELLO, John, Dr | Director | 2007-07-30 | 2009-07-09 |
| GARRAWAY, Richard, Dr | Director | 2005-05-05 | 2007-10-30 |
| HAND, Christopher William, Dr | Director | 2010-03-08 | 2021-04-20 |
| HOFMANN, Oliver, Dr | Director | 2014-09-29 | 2015-11-30 |
| POULIOS, Constas | Director | 2009-11-16 | 2012-03-22 |
| POULIOS, Constas | Director | 2009-05-13 | 2009-08-17 |
| RICHARDS, Jemima | Director | 2001-11-27 | 2002-07-30 |
| ROSS, Melanie | Director | 2021-04-20 | 2023-10-18 |
| SEARLE, Susan Jane | Director | 2001-11-27 | 2003-04-27 |
| TOBIN, Jonathan Leslie, Dr | Director | 2013-08-13 | 2016-06-23 |
| TODD, Rebecca, Dr | Director | 2012-03-22 | 2013-07-12 |
| TOPOGLIDIS, Emmanuel, Dr | Director | 2008-11-13 | 2012-03-22 |
| WOODFORD, Peter | Director | 2009-02-01 | 2015-03-17 |
| WRIGHT, Christopher John, Dr | Director | 2006-11-01 | 2010-02-26 |
| INSTANT COMPANIES LIMITED | Corporate Nominee Director | 2001-09-24 | 2001-09-24 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Touchstone Innovations Businesses Llp | Corporate entity | Shares 25–50% | 2016-04-06 | Ceased 2018-05-11 |
| Abingdon Health Plc | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 169 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-11-26 | AA | accounts | Accounts with accounts type full | |
| 2025-09-25 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-05-12 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-05-12 | AP03 | officers | Appoint person secretary company with name date | |
| 2025-05-12 | AP01 | officers | Appoint person director company with name date | |
| 2025-01-31 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-11-27 | AA | accounts | Accounts with accounts type full | |
| 2024-10-04 | CH01 | officers | Change person director company with change date | |
| 2024-09-24 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-26 | AA | accounts | Accounts with accounts type full | |
| 2023-10-18 | AP03 | officers | Appoint person secretary company with name date | |
| 2023-10-18 | TM02 | officers | Termination secretary company with name termination date | |
| 2023-10-18 | TM01 | officers | Termination director company with name termination date | |
| 2023-09-29 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-12-13 | AA | accounts | Accounts with accounts type full | |
| 2022-11-01 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-07-04 | TM02 | officers | Termination secretary company with name termination date | |
| 2022-07-04 | AP03 | officers | Appoint person secretary company with name date | |
| 2022-07-04 | AP01 | officers | Appoint person director company with name date | |
| 2022-03-23 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.